AbbVie's $175M investment in a Tempe manufacturing facility is part of a larger expansion strategy. Here's what the Chicago ...

Minaris and Genetix Biotherapeutics have expanded their manufacturing partnership to increase commercial-scale production of ...

ChemWerth, Inc., a global leader in generic active pharmaceutical ingredient (API) development and supply, continues to expand its footprint and strengthen its position in the Indian market. To ...

Hyderabad: Telangana's Drugs Control Administration (DCA) has detected multiple instances of pharmaceutical companies ...

Mandara Biopharma Inc., a privately held U.S.-based biopharmaceutical company focused on novel therapies for central nervous system (CNS) disorders, today announced that it has filed an ...

The agency outlined the adjustments it's willing to make to "remove barriers and perceived misconceptions" for innovative medicines.

Wilmington PharmaTech ("WPT"), a U.S.-based specialty contract research, development and manufacturing organization (CRDMO) focused on complex custom small molecule API, today announced that it has ...

Clinical and commercial quality controls are eased as the FDA looks to expedite therapy approvals in areas of unmet need.

Now, the Chicago-based pharma is heading southwest as it charts the next leg of its stateside investment tour.

Jubilant Biosys Limited, a wholly owned subsidiary of Jubilant Pharmova Limited, and a global CRDMO operating from five sites across India and Europe, – announced the opening of a new discovery and ...

AbbVie agreed to acquire a device manufacturing facility in Tempe, Ariz., and the rights to the SmartDose 3.5 milliliter drug-delivery system from West Pharmaceutical Services as part of a deal worth ...

As Indian pharma pivots toward innovation and sustainability, Granules India charts strong growth, R&D and global ambitions ...